Institutional Ownership Biocryst Pharmaceuticals Inc (BCRX)
This table provides information about the institutional ownership of Biocryst Pharmaceuticals Inc (BCRX). We have compiled data on the 278 institutions that hold shares in the stock, with a total of 172 Million shares, which have been reported (via 13F filing form) to have a value of $1.34 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
20,306,596
shares
|
$158 Million
0.0% of portfolio
|
Q3 2024
Added 8.19%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
19,956,255
shares
|
$155 Million
0.0% of portfolio
|
Q2 2024
Added 8.22%
|
|
Avoro Capital Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
11,865,000
shares
|
$92.3 Million
1.36% of portfolio
|
Q3 2024
Reduced 5.61%
|
|
Kynam Capital Management, LP
Princeton, NJ |
Nov 14, 2024 Q3 2024 |
9,085,368
shares
|
$70.7 Million
5.66% of portfolio
|
Q3 2024
Added 2.93%
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
8,849,588
shares
|
$68.8 Million
0.0% of portfolio
|
Q3 2024
Reduced 5.32%
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2024 Q3 2024 |
8,135,804
shares
|
$63.3 Million
1.15% of portfolio
|
Q2 2024
Added 62.88%
|
|
Alkeon Capital Management LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
7,093,822
shares
|
$55.2 Million
0.09% of portfolio
|
Q3 2024
Reduced 0.08%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
5,286,536
shares
|
$41.1 Million
0.04% of portfolio
|
Q2 2023
Reduced 5.91%
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
4,837,985
shares
|
$37.6 Million
0.0% of portfolio
|
Q3 2024
Added 2.71%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
4,814,549
shares
|
$37.5 Million
0.01% of portfolio
|
Q3 2024
Added 7.1%
|
|
Rp Management, LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
3,846,154
shares
|
$29.9 Million
36.09% of portfolio
|
Q4 2021
New holding
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
3,622,358
shares
|
$28.2 Million
0.94% of portfolio
|
Q3 2024
Added 0.09%
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Nov 12, 2024 Q3 2024 |
3,338,062
shares
|
$26 Million
0.01% of portfolio
|
Q3 2024
Added 16.85%
|
|
Gw&K Investment Management, LLC
Boston, MA |
Nov 07, 2024 Q3 2024 |
3,277,600
shares
|
$25.5 Million
0.21% of portfolio
|
Q3 2024
Reduced 3.73%
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
2,320,529
shares
|
$18.1 Million
0.0% of portfolio
|
Q3 2024
Reduced 8.29%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
2,252,749
shares
|
$17.5 Million
0.0% of portfolio
|
Q3 2024
Added 15.59%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
2,181,012
shares
|
$17 Million
0.04% of portfolio
|
Q3 2024
Added 13.62%
|
|
Rice Hall James & Associates, LLC
|
Oct 28, 2024 Q3 2024 |
2,163,743
shares
|
$16.8 Million
0.97% of portfolio
|
Q3 2024
Added 4.04%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
1,887,994
shares
|
$14.7 Million
0.0% of portfolio
|
Q3 2024
Added 5.76%
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
1,860,925
shares
|
$14.5 Million
0.0% of portfolio
|
Q3 2024
Added 6.05%
|
|
Stifel Financial Corp
St. Louis, MO |
Nov 14, 2024 Q3 2024 |
1,843,289
shares
|
$14.3 Million
0.02% of portfolio
|
Q3 2024
Reduced 0.02%
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Nov 14, 2024 Q3 2024 |
1,792,908
shares
|
$13.9 Million
0.05% of portfolio
|
Q3 2024
Reduced 30.8%
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2024 Q3 2024 |
1,772,501
shares
|
$13.8 Million
0.0% of portfolio
|
Q3 2024
Reduced 4.99%
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
1,760,808
shares
|
$13.7 Million
0.03% of portfolio
|
Q3 2024
Added 5.16%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
1,739,080
shares
|
$13.5 Million
0.0% of portfolio
|
Q3 2024
Added 10.21%
|